66th Annual Meeting of the Japanese Society of Neurology

Norihito Uemura^1,2,4, Jun Ueda¹, Chang Jiarui¹, Tetsuya Hirato¹, Tomoyuki Ishimoto¹, Miki Oono^1,2, Shuichi Matsuzawa^1,2, Riki Matsumoto¹, Hodaka Yamakado^1,2, Ryosuke Takahashi^1,3 (1.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 2.Department of Therapeutics for Multiple System Atrophy, Kyoto University Graduate School of Medicine, Japan, 3.Research Administration Center, Kyoto University, Japan, 4.Department of Neurological Disease Control, Osaka Metropolitan University Graduate School of Medicine, Japan)

Yaping Shao¹, Huijia Yang¹, Yang Ni¹, Guowang Xu², Weidong Le¹ (1.The First Affiliated Hospital, Dalian Medical University, China, 2.Dalian Institute of Chemical Physics, Chinese Academy of Sciences, China)

Jing-cong Zhuang¹, Qing-wei Yang¹, Ping-ping Cai², Long-ling Li¹, Zhong-jie Chen¹, Rong Wang¹ (1.Department of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China, 2.Department of Neurology, Xiamen Humanity Hospital Fujian Medical University, Xiamen, China, China)

Makito Hirano¹, Makoto Samukawa¹, Satoko Miyatake^2,3, Yuko Yamagishi¹, Chiharu Isono⁴, Kazumasa Saigoh¹, Eriko Koshimizu², Takeshi Mizuguchi², Atsushi Terayama¹, Kanako Fujii¹, Yoshiyuki Mitsui¹, Naomichi Matsumoto², Yoshitaka Nagai¹ (1.Kindai University, Department of Neurology, Japan, 2.Yokohama City University Graduate School of Medicine, Department of Human Genetics, Japan, 3.Yokohama City University Hospital, Department of Clinical Genetics, Japan, 4.Kindai University Hospital, Division of Rehabilitation Medicine, Japan)

Tetsuya Hirato¹, Masanori Sawamura¹, Hideo Tsukada², Tomokazu Nakako³, Tatsuo Nakayama³, Kazuhito Ikeda³, Chih-yang Cheng^4,5, Kaoru Isa⁵, Masashi Nakamura⁵, Etsuro Nakanishi¹, Norihito Uemura^1,6,7, Hodaka Yamakado^1,6, Riki Matsumoto¹, Tadashi Isa⁵, Ryosuke Takahashi⁸, Hirotaka Onoe^9,10 (1.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 2.Central Research Laboratory, Hamamatsu Photonics K.K., Japan, 3.Sumitomo Pharma Co., Ltd, Japan, 4.Kyoto University Institute for the Advanced Study of Human Biology, Japan, 5.Department of Physiology and Neurobiology, Kyoto University Graduate School of Medicine, Japan, 6.Department of Therapeutics for Multiple System Atrophy, Kyoto University Graduate School of Medicine, Japan, 7.Osaka Metropolitan University Graduate School of Medicine Department of Basic Medical Science, Japan, 8.Kyoto University Research Administration Center (KURA), Japan, 9.Human Brain Research Center, Kyoto University Graduate School of Medicine, Japan, 10.Kobe Gakuin University, Faculty of Pharmaceutical Science, Laboratory of Neuropsychopharmacology, Japan)

Yoshinobu Amakusa¹, Hiroto Ito¹, Ryosuke Takeuchi², Yohei Iguchi¹, Akinobu Ohba³, Kenta Kobayashi⁴, Tomonari Hamaguchi⁵, Tomoki Hirunagi¹, Kentaro Sahashi¹, Hiroshi Yamaguchi⁶, Fumitaka Osakada², Masahisa Katsuno¹ (1.Department of Neurology, Nagoya University Graduate school of Medicine, Japan, 2.Laboratory of Cellular Pharmacology, Department of Basic Medical Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University, Japan, 3.3.Cell physiology, Nagoya University Graduate school of Medicine, Japan, 4.Section of Viral Vector Development, Center for Genetic Analysis of Behavior, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Japan, 5.Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Japan, 6.Division of Multicellular Circuit Dynamics, National Institute for Physiological Sciences, Japan)